Tina-Quant Hemoglobin A1C GEN.2 Test
Assay, Glycosylated Hemoglobin. 510(k) K052464, from Roche Diagnostics Corp. (Indianapolis, IN). Product code LCP, class 2.
As of Nov 19, 2026, K052464 is an FDA 510(k) held by Roche Diagnostics Corp., substantially equivalent on Sep 30, 2005 after 22 days, with no recalls tied to it in FDA's recall database.
- Review time: 22 days
- Recalls: 0
- Cited as a predicate by: 1 device
The Tina-Quant Hemoglobin A1c Gen.2 test is an in vitro diagnostic reagent system intended for the quantitative determination of percent hemoglobin A1c in whole blood. HbA1c results are useful for monitoring of long-term blood glucose control in individuals with diabetes mellitus.
- Tina-Quant Hemoglobin A1CK934070 · Boehringer Mannheim Corp. · Oct 11, 1994
- Tina-Quant Hemoglobin A1C GEN.2 Test SystemK072714 · Roche Diagnostics Corp. · Apr 18, 2008
- Q-Pad Test SystemK231465 · Qurasense · Dec 6, 2023
- Document
- 510(k) summary (PDF) ↗
- Type
- Special
- Received
- Sep 8, 2005
- Review panel
- Hematology
- Regulation
- 21 CFR 864.7470
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files